Page 385 - SAHCS HIVMed Journal Vol 20 No 1 2019
P. 385

Page 4 of 6  Original Research


              TABLE 2: Patient characteristics as risk factors for non-viral sexually transmitted infections.
              Risk factor                All women       Non-viral STI positive    OR (95% CI, p)   aOR (95% CI, p)
                                          N = 385            n = 79
                                       n        %         n        %
              Age (years)
              ≤ 25                     20       5.2       7        35.0            -                     -
              26–35                    80       21.9      22       27.5      0.51 (0.25–1.99, 0.51)      -
              > 35                    285       78.1      50       17.5      0.39 (0.09–1.04, 0.06)      -
              Education
              None                     24       6.2       9        37.5            -                     -
              Primary                  62       16.1      19       30.7      0.73 (0.27–1.98, 0.54)  0.79 (0.28–2.24, 0.65)
              Secondary               242       62.9      47       19.4      0.40 (0.17–0.97, 0.04)  0.39 (0.15–1.00, 0.05)
              Tertiary                 57       14.8      4        7.0       0.13 (0.03–0.47, < 0.01)  0.10 (0.03–0.39, < 0.01)
              Lifetime partners
              1                        91       23.6      9        9.9             -                     -
              2                        88       22.9      13       14.8      1.57 (0.64–3.90, 0.32)  1.55 (0.60–3.99, 0.37)
              ≥ 3                     206       53.5      57       27.7      3.49 (1.64–7.40, < 0.01)  3.27 (1.49–7.19, < 0.01)
              Last sex partner type
              Casual                   12       3.1       0         -              -                     -
              Regular                 373       96.9      79       21.2            -                     -
              Condom use at last sexual intercourse
              Yes                     246       63.9      53       21.5            -                     -
              No                      139       36.1      26       18.7      0.83 (0.50–1.41, 0.51)      -
              STI signs and symptoms
              No                      312       81.0      54       17.3            -
              Yes                      73       19.0      25       34.3      2.49 (1.41–4.38, < 0.01)  2.89 (1.54–5.40, < 0.01)
              Previous STI
              No                      219       56.9      39       17.8            -                     -
              Yes                     166       43.1      40       24.1      1.46 (0.89–2.40, 0.13)      -
              Age at sexual debut (years)
              < 16                     25       6.5       7        28.0            -                     -
              16–20                   237       61.6      59       24.9      0.85 (0.34–2.14, 0.73)  1.30 (0.49–3.51, 0.60)
              > 20                    123       31.9      13       10.6      0.39 (0.16–0.93, 0.03)  0.60 (0.19–1.86, 0.37)
              Sexual abuse or domestic violence
              No                      333       86.5      68      (86.1            -                     -
              Yes                      52       13.5      11       13.9      1.05 (0.51–2.14, 0.90)      -
              OR, odds ratio; CI, confidence interval; STI, sexually transmitted infection.
              Note: Bold values indicate statistically significant, p-value < 0.05

              Zimbabwean cohorts. Gwanzura et al. reported a prevalence   United States are attributable to TV infections and up to
              of 2.3% in male factory workers. The prevalence of active   2.0% of all HIV transmissions in the United States may be
              syphilis in HIV-infected women and all antenatal clinic   related to TV infection. 22
              attendees  has  been previously  reported  at 4.0% and  1.2%,
              respectively. 17,18,19  This increase is in keeping with global   The prevalence of infection with chlamydia varies
              trends of syphilis incidence and higher prevalence in   significantly between regions, countries and risk groups. The
              PLWH. 7,20  Rekart et al. suggest a novel hypothesis that ART   prevalence of NG and CT in our study was 1.8% and 2.1%,
              may potentially alter both innate and acquired immune   respectively. Studies conducted in Kenya, Zimbabwe, Nigeria
              responses in ways that may lead to enhanced susceptibility   and South  Africa have shown that the prevalence of CT
                      21
              to syphilis.  With a larger proportion of patients now taking   varied between 6.0% and 20.0% in these countries. 23,24,25  A
              ART (93.0% in this study), this enhanced susceptibility could   Zimbabwean study investigating the prevalence of NG and
              be a significant factor contributing to the rise in incident   CT in 5448 men and women congregating at bottle stores
              syphilis in HIV-infected treated adults. The high prevalence   revealed a baseline prevalence of 2.2% and 3.8%, respectively.
              of syphilis in our study provides further evidence to support   The HIV status of these individuals was, however, not
              the need to enhance the surveillance of syphilis and provide   recorded. The factors associated with incident infection were
              effective syphilis control programmes within existing HIV   being female and having more than one sexual partner. The
              care and treatment programmes.                        proportion of patients with incident infection not reporting
                                                                    symptoms was greater than 75.0% for both infections; 26,27  this
              The second most prevalent non-viral STI in this study was   is consistent with other studies in PLWH in the region.
              TV, which was confirmed in 8.0% of the participants.
              Similar to other STIs, it is increasingly recognised that TV   An HSV 2 seropositivity rate of 52.0% is in keeping with
                                                                                                              27
              plays an important role in increasing the risk of both   global  published  rates  in  PLWH  of  50.0%  –  90.0%.   Data
              acquisition and onward transmission of HIV. Using     from a review conducted by Smith and Robinson showed
              mathematical models, Quinlivan et al. estimated that 22.0%   that up to 90.0% of PLWH in some settings were coinfected
                                                                              27
              of  projected  HIV  transmissions from women in the   with HSV-2.  Herpes Simplex Virus type 2and HIV are
                                           http://www.sajhivmed.org.za 378  Open Access
   380   381   382   383   384   385   386   387   388   389   390